News & insights
Merck
Articles from Apotek Analytics.
-

US loses measles elimination status while Isomorphic raises record $5bn
Global health authorities said the United States has lost its measles elimination status after several states faced their worst outbreaks in nearly three decades, and the CDC and partners set out plans to stop the outbreaks and restore it.
-

Lilly’s retatrutide beats Ozempic. Artiva drops its autoimmune cell therapy after two trial deaths
Eli Lilly’s ‘triple-G’ drug retatrutide beat Novo Nordisk’s Ozempic on blood sugar and weight loss in a head-to-head phase 3 trial in type 2 diabetes, though with more side effects and treatment discontinuations.
-

FDA approves GSK and Ionis hepatitis B drug that offers some patients a functional cure
The FDA approved bepirovirsen, a first of its kind antisense injection for chronic hepatitis B from GSK and Ionis, as dealmaking led the rest of the week’s coverage.
-

FDA approves AbbVie’s first-in-class Parkinson’s pill as pharma deal-making accelerates
The FDA approved AbbVie’s tavapadon, branded Juvmo, for adults with Parkinson’s disease, as deal-making dominated the rest of the week.